Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Annals of the Rheumatic Diseases Année : 2003

Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs

Résumé

Dual 5-LOX/COX inhibitors are potential new drugs to treat inflammation. They act by blocking the formation of both prostaglandins and leucotrienes but do not affect lipoxin formation. Such combined inhibition avoids some of the disadvantages of selective COX-2 inhibitors and spares the gatrointestinal mucosa.

Dates et versions

hal-01705863 , version 1 (09-02-2018)

Identifiants

Citer

Johanne Martel-Pelletier, Daniel Lajeunesse, Pascal Reboul, Jean-Pierre Pelletier. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Annals of the Rheumatic Diseases, 2003, 62 (6), pp.501 - 509. ⟨10.1136/ard.62.6.501⟩. ⟨hal-01705863⟩

Collections

UNIV-LORRAINE
22 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More